MOLLIE COTTY: Open Payments
NPI 1093141004 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 10 payments from 7 companies in 2025. Trend: 2023 $766 · 2024 $457 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $71 |
| ABBVIE INC. | 3 | $46 |
| Novo Nordisk Inc | 1 | $25 |
| Amgen Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Dexcom G6 Transmitter, UBRELVY, Ozempic, KRYSTEXXA, INJECTAFER, SHINGRIX, QULIPTA.
Industry payments across SC — which companies pay providers there.
